This article provides a detailed, current protocol and framework for researchers targeting CD34+ hematopoietic stem and progenitor cells (HSPCs) for gene editing.
This article provides a detailed analysis of two leading genome-wide, unbiased off-target detection methods for CRISPR-Cas systems: CAST-Seq (Circularization for Amplification and Sequencing of Translocations) and LAM-HTGTS (Linear Amplification-Mediated High-Throughput...
This article provides a comprehensive analysis of the CARRD (CRISPR-Assisted RNA Detection with Reverse Transcription) platform for the direct, amplification-free detection of viral RNA.
This article provides a comprehensive framework for the bioinformatic analysis of Protospacer Adjacent Motif (PAM) distribution in viral and phage genomes.
This article provides a detailed guide for researchers and drug development professionals on validating CRISPR off-target effects.
This comprehensive 2024 benchmarking review provides a critical analysis of current methods for detecting off-target effects in genome editing.
This article provides a comprehensive guide for researchers and drug development professionals on evaluating engineered Cas nucleases with altered PAM specificities against the canonical wild-type SpCas9.
This article provides a detailed resource for researchers and drug development professionals on the BLESS (Direct In Situ Breaks Labeling, Enrichment on Streptavidin, and Next-Generation Sequencing) and BLISS (Breaks Labeling...
This article provides a detailed comparison of two premier cytosine base editors, BE4max and Sdd7, tailored for researchers and drug developers.
This comprehensive review details the pivotal role of the BCL11A transcription factor in silencing fetal hemoglobin (HbF) and its emergence as a prime therapeutic target for sickle cell disease (SCD).